학술논문
PDB18 COST-EFFECTIVENESS OF ADD-ON PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) THERAPY IN DIABETIC VERSUS NON-DIABETIC PATIENTS WITH DYSLIPIDEMIA: A UK PERSPECTIVE
Document Type
Abstract
Author
Source
In Value in Health 2005 8(6):A159-A160
Subject
Language
ISSN
1098-3015